US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 0.890
  • -0.050-5.35%
Close May 13 16:00 ET
36.56MMarket Cap-556P/E (TTM)

Achilles Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-22.93%14.3M
-3.99%75.26M
-14.54%19.51M
19.10%19.1M
-11.94%18.09M
-2.19%18.55M
22.10%78.38M
23.69%22.83M
1.88%16.03M
26.13%20.55M
Selling and administrative expenses
-11.23%4.16M
-19.46%17.01M
-8.49%3.62M
-19.37%4.38M
-25.16%4.32M
-21.33%4.69M
-3.87%21.12M
-40.51%3.96M
7.86%5.44M
5.97%5.77M
-General and administrative expense
-11.23%4.16M
-19.46%17.01M
-8.49%3.62M
-19.37%4.38M
-25.16%4.32M
-21.33%4.69M
-3.87%21.12M
-40.51%3.96M
7.86%5.44M
5.97%5.77M
Research and development costs
-26.88%10.14M
1.72%58.25M
-15.81%15.89M
38.83%14.71M
-6.78%13.77M
6.56%13.87M
35.62%57.26M
59.87%18.88M
-0.93%10.6M
36.26%14.78M
Operating profit
22.93%-14.3M
3.99%-75.26M
14.54%-19.51M
-19.10%-19.1M
11.94%-18.09M
2.19%-18.55M
-22.10%-78.38M
-23.69%-22.83M
-1.88%-16.03M
-26.13%-20.55M
Net non-operating interest income expense
Other net income (expense)
83.50%2M
-16.90%6.08M
217.61%1.39M
-33.62%2.39M
-62.95%1.21M
-33.03%1.09M
133.58%7.32M
-622.57%-1.18M
28.26%3.6M
2,140.41%3.27M
Other non- operating income (expenses)
83.50%2M
-16.90%6.08M
217.61%1.39M
-33.62%2.39M
-62.95%1.21M
-33.03%1.09M
133.58%7.32M
-622.57%-1.18M
28.26%3.6M
2,140.41%3.27M
Income before tax
29.58%-12.3M
2.66%-69.17M
24.53%-18.13M
-34.35%-16.71M
2.29%-16.88M
-0.70%-17.46M
-16.38%-71.07M
-31.70%-24.02M
3.84%-12.44M
-7.01%-17.28M
Income tax
-152.27%-23K
342.34%491K
1,131.71%505K
-158.54%-24K
-342.86%-34K
193.33%44K
200.00%111K
1,125.00%41K
156.25%41K
7.69%14K
Net income
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
3.65%-12.48M
-7.01%-17.29M
Net income continuous Operations
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
3.65%-12.48M
-7.01%-17.29M
Minority interest income
Net income attributable to the parent company
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
3.65%-12.48M
-7.01%-17.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
3.65%-12.48M
-7.01%-17.29M
Basic earnings per share
31.82%-0.3
4.40%-1.74
25.81%-0.46
-31.25%-0.42
4.55%-0.42
2.22%-0.44
14.55%-1.82
-40.91%-0.62
5.88%-0.32
2.22%-0.44
Diluted earnings per share
31.82%-0.3
4.40%-1.74
25.81%-0.46
-31.25%-0.42
4.55%-0.42
2.22%-0.44
14.55%-1.82
-40.91%-0.62
5.88%-0.32
2.22%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -22.93%14.3M-3.99%75.26M-14.54%19.51M19.10%19.1M-11.94%18.09M-2.19%18.55M22.10%78.38M23.69%22.83M1.88%16.03M26.13%20.55M
Selling and administrative expenses -11.23%4.16M-19.46%17.01M-8.49%3.62M-19.37%4.38M-25.16%4.32M-21.33%4.69M-3.87%21.12M-40.51%3.96M7.86%5.44M5.97%5.77M
-General and administrative expense -11.23%4.16M-19.46%17.01M-8.49%3.62M-19.37%4.38M-25.16%4.32M-21.33%4.69M-3.87%21.12M-40.51%3.96M7.86%5.44M5.97%5.77M
Research and development costs -26.88%10.14M1.72%58.25M-15.81%15.89M38.83%14.71M-6.78%13.77M6.56%13.87M35.62%57.26M59.87%18.88M-0.93%10.6M36.26%14.78M
Operating profit 22.93%-14.3M3.99%-75.26M14.54%-19.51M-19.10%-19.1M11.94%-18.09M2.19%-18.55M-22.10%-78.38M-23.69%-22.83M-1.88%-16.03M-26.13%-20.55M
Net non-operating interest income expense
Other net income (expense) 83.50%2M-16.90%6.08M217.61%1.39M-33.62%2.39M-62.95%1.21M-33.03%1.09M133.58%7.32M-622.57%-1.18M28.26%3.6M2,140.41%3.27M
Other non- operating income (expenses) 83.50%2M-16.90%6.08M217.61%1.39M-33.62%2.39M-62.95%1.21M-33.03%1.09M133.58%7.32M-622.57%-1.18M28.26%3.6M2,140.41%3.27M
Income before tax 29.58%-12.3M2.66%-69.17M24.53%-18.13M-34.35%-16.71M2.29%-16.88M-0.70%-17.46M-16.38%-71.07M-31.70%-24.02M3.84%-12.44M-7.01%-17.28M
Income tax -152.27%-23K342.34%491K1,131.71%505K-158.54%-24K-342.86%-34K193.33%44K200.00%111K1,125.00%41K156.25%41K7.69%14K
Net income 29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M3.65%-12.48M-7.01%-17.29M
Net income continuous Operations 29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M3.65%-12.48M-7.01%-17.29M
Minority interest income
Net income attributable to the parent company 29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M3.65%-12.48M-7.01%-17.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M3.65%-12.48M-7.01%-17.29M
Basic earnings per share 31.82%-0.34.40%-1.7425.81%-0.46-31.25%-0.424.55%-0.422.22%-0.4414.55%-1.82-40.91%-0.625.88%-0.322.22%-0.44
Diluted earnings per share 31.82%-0.34.40%-1.7425.81%-0.46-31.25%-0.424.55%-0.422.22%-0.4414.55%-1.82-40.91%-0.625.88%-0.322.22%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg